Venous thromboembolism prophylaxis and clinical consequences in medically ill patients

American Journal of Therapeutics

Volumn 20, Issue 2, 2013, Pages 132-142

  Baser, Onur ^a,b   Liu, Xianchen ^c,d   Phatak, Hemant ^e   Wang, Li ^a   Mardekian, Jack ^c   Kawabata, Hugh ^e   Petersel, Danielle ^f   Hamilton, Melissa ^e   Ramacciotti, Eduardo ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b STATINMED RESEARCH   (United States)

^c PFIZER INC   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f Pfizer Primary Care Business Unit   (United States)

Author keywords

Anticoagulant use; Medically ill; Venous thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; TINZAPARIN;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPRESSION STOCKING; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; EMBOLISM PREVENTION; FEMALE; HEALTH CARE COST; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INFECTION; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OBESITY; OUTPATIENT; PARALYSIS; PARESIS; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; RHEUMATIC FEVER; RISK REDUCTION; SEPSIS; THROMBOSIS PREVENTION; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK; STOCKINGS, COMPRESSION; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84875168119     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31826910dd     Document Type: Article

References (40)

1. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28: 370-372
2. U.S. Census Bureau. Nation's population to reach 300 million on Oct. 17. Available at: Www.census.gov/ newsroom/releases/archives/population/cb06-156. html. Accessed June 7, 2010
3. American Heart Association. Venous thromboembolism -statistics. Statistical fact sheet, 2004. Available at: Www. americanheart.org/downloadable/ heart/1136823273598 VenousThromb06.pdf. Accessed October 22, 2009
4. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med. 1991;151: 933-938
5. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: An analysis using multiple-cause mortality data. Arch Intern Med. 2003;163:1711-1717
6. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. J Thromb Haemost. 2006;2001:452-463
7. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S-400S.
8. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992;152: 1660-1664
9. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet. 2008;371:387-394
10. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med. 1998;158:585-593
11. Morrell MT, Truelove SC, Barr A. Pulmonary embolism. Br Med J. 1963;2:830-835
12. Coon WW, Willis PW III, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973;48:839-846
13. Kierkegaard A. Incidence of acute deep venous thrombosis in two districts: A phlebographic study. Acta Chir Scand. 1980;146:267-269
14. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med. 1991;151:933-938
15. Koster T, Rosendaal FR, de Ronde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: The Leiden Thrombophilia Study. Lancet. 1993;342:1503-1506
16. Ollendorf DA, Vera-Llonch M, Oster G. Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients. Am J Health Syst Pharm. 2002; 59:1750-1754
17. Tapson VF. Medical progress: Acute pulmonary embolism. N Engl J Med. 2008;358:1037-1052
18. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-2264
19. Amin AN, Lin J, Lenhart G, et al. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis. Thromb Haemost. 2009;102: 321-326
20. Baser O, Palmer L, Stephenson J. The estimation power of alternative comorbidity indices. Value Health. 2008;11: 946-955
21. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994; 47:1245-1251
22. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996; 49:1429-1433
23. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care. 2004;42: 355-360
24. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care.1998;36:8-27
25. Baser O. Propensity score matching with limited overlap. Econ Bull. 2007;9:1-8
26. Baser O. Choosing propensity score matching over regression adjustment for causal inference: When, why and how it makes sense. J Med Econ. 2007;10:379-391
27. Baser O. Too much ado about propensity score models? Comparing methods of propensity score matching. Value Health. 2006;9:377-385
28. Baser O. Using propensity score matching techniques for average treatment effect: Application to Triptan use. Proc Am Stat Assoc. 2007;1:4334-4339
29. Baser O, Crown HW, Pollicino C. Guidelines for selecting among different types of bootstraps. Curr Med Res Opin. 2006;22:799-808
30. U.S. Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2008. Washington, DC: US Department of Health and Human Services. Available at: Www.surgeongeneral.gov/topics/deepvein/ calltoaction/call-To-Action-on-dvt-2008. pdf. Accessed January 18, 2011
31. Agency for Healthcare Quality and Research. National quality measures clearinghouse. Available at: Www. qualitymeasures.ahrq.gov/summary/summary.aspx? doc-id=12727. Accessed June 22, 2010
32. Agency for Healthcare Research and Quality. Preventing hospital-Acquired venous thromboembolism, a guide for effective quality improvement. Available at: Www.ahrq. gov/qual/vtguide/ vtguide.pdf. Accessed October 22, 2009
33. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-175S.
34. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-453S.
35. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259-262
36. Lobo BL, Vaidean G, Broyles J, et al. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med. 2009;4: 417-422
37. Pandey A, Patni N, Singh M, et al. Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag. 2009;5:643-648
38. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely Ill hospitalized medical patients: Findings from the international medical prevention registry on venous thromboembolism. Chest. 2007; 132:936-945
39. Baser O. Too much ado about instrumental variable approach: Is the cure worse than the disease? Value Health. 2009;12:1201-1209
40. Baser O, Wang L, Supina D, et al. Anticoagulation prophylaxis practice patterns in patients undergoing total hip or total knee replacement in a U.S. health plan. Formulary. 2011;46:486-500